Your browser doesn't support javascript.
loading
Left Internal Thoracic Artery versus Saphenous Vein Grafts to Left Anterior Descending Artery after Isolated Coronary Artery Bypass Surgery.
Luthra, Suvitesh; Masraf, Hannah; Mohamed, Mostafa Elbadry; Malvindi, Pietro G; Sef, Davorin; Miskolczi, Szabolcs; Velissaris, Theodore.
Affiliation
  • Luthra S; Wessex Cardiothoracic Centre, University Hospital Southampton, Southampton SO16 6YD, UK.
  • Masraf H; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK.
  • Mohamed ME; Division of Surgery, Kingston Hospital NHS Foundation Trust, Kingston upon Thames KT2 7QB, UK.
  • Malvindi PG; Wessex Cardiothoracic Centre, University Hospital Southampton, Southampton SO16 6YD, UK.
  • Sef D; Department of Cardiothoracic Surgery, Faculty of Medicine, Assiut University, Assiut 71111, Egypt.
  • Miskolczi S; Cardiac Surgery Unit, Lancisi Cardiovascular Center, Ospedali Riuniti delle Marche, Polytechnic University of Marche, 60126 Ancona, Italy.
  • Velissaris T; Department of Cardiac Surgery, University Hospitals of Leicester, Leicester LE5 4PW, UK.
Life (Basel) ; 14(3)2024 Mar 14.
Article in En | MEDLINE | ID: mdl-38541709
ABSTRACT

BACKGROUND:

This study compared perioperative outcomes and long-term survival of saphenous vein grafts (SVGs) versus left internal thoracic artery (LITA) to left anterior descending artery (LAD) in isolated coronary artery bypass graft surgery (CABG).

METHODS:

In this retrospective, single-centre study, we included patients with primary isolated CABG from January 2001 to July 2022. Baseline demographics were compared between SVG-LAD and LITA-LAD. Univariable and multivariable regressions were performed for predictors of in-hospital death. Propensity score matching was performed for LITA-LAD vs. SVG-LAD. Kaplan-Meier survival curves were generated for comparison of survival. Cox proportional hazards model was used for predictors of survival.

RESULTS:

A total of 8237 patients (1602 SVG-LAD/6725 LITA-LAD) were included. Median age was 67.9 years (LITA-LAD; 67.1 years vs. SVG-LAD; 71.7 years, p < 0.01). A total of 1270 pairs of SVG-LAD were propensity-matched to LITA-LAD. In matched cohorts, in-hospital mortality (0.8% vs. 1.6%, LITA-LAD and SVG-LAD respectively; p = 0.07), deep sternal wound infection, new cerebrovascular events, renal replacement therapy and hospital stay >30 days were similar. SVG-LAD did not adversely affect in-hospital mortality (OR; 2.03, CI; 0.91, 4.54, p = 0.08). Median long-term survival was similar between the groups (13.7 years vs. 13.1 years for LITA-LAD and SVG-LAD respectively, log rank p < 0.31). SVG-LAD was not a predictor of adverse long-term survival. (HR; 1.06, 95% CI; 0.92, 1.22, p < 0.40). Long-term survival was better with LITA-LAD for LVEF <30% (log rank p < 0.03).

CONCLUSIONS:

There was no difference in the propensity-matched cohorts for use of SVG vs. LITA to the LAD. Further contemporary long-term studies are needed for substantiation.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Life (Basel) Year: 2024 Document type: Article Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Life (Basel) Year: 2024 Document type: Article Country of publication: Switzerland